Risimtinib
Risimtinib (Risimtinibum) is a FGFR1 inhibitor with an IC50 of 2.1 nM. Risimtinib inhibits the proliferation of FGFR1-positive cancer cells. Risimtinib is used for the research of myeloid leukemia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2126751-11-7
- Formule: C30H31N5O3
- Masse moléculaire:509.60
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
FGFR1 2.1 nM (IC50) |
Risimtinib (compound 19a) potently inhibits purified FGFR1 kinase activity with an IC50 of 2.1 nM[1].
Risimtinib inhibits the proliferation of FGFR1-translocated KG-1 leukemia cells with an IC50 of 14.9 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2126751-11-7
-
Masse moléculaire 509.60
-
Formule C30H31N5O3
-
SMILES
CNC(C1=CC=CC2=C1C=CC(OC3=CC=NC(NC(C4=CC=C(N5C[C@H](N[C@H](C5)C)C)C=C4)=O)=C3)=C2)=O
-
Synonyms
Risimtinibum
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)